Ligand Pharmaceuticals (Nasdaq: LGND) has entered into a royalty financing agreement with Castle Creek Biosciences, providing ...

Shares of Sweden’s immune-oncology firm Alligator Bioscience were up almost 160% at 0.11 kronor by early afternoon today, ...

Candel Therapeutics (Nasdaq: CADL) has released final data from a Phase II trial of its investigational immunotherapy, ...

Swiss biotech company Idorsia has revised its collaboration terms with Viatris, reducing its financial commitment to the ...

Cardiovascular diseases specialist Kiniksa Pharmaceuticals International has announced updates to its pipeline alongside ...

Positive high-level results from a planned interim analysis of the SERENA-6 Phase III trial showed that AstraZeneca’s ...

Privately-held BridGene Biosciences has announced a strategic collaboration and licensing agreement with Japan’s Takeda. The ...

Israel-headquartered Teva Pharmaceutical Industries’ US subsidiary and France’s and Medincell announced that the supplemental ...

US drugmaker Eli Lilly has launched 7.5mg and 10mg Zepbound (tirzepatide) single-dose vials for the treatment of obesity.

US pharma major Eli Lilly has announced a deal with San Diego-based Organovo Holdings, a biotech focused on developing novel ...

Ryvu Therapeutics saw its shares tumble nearly 13% to 22.70 zloty by close of trading today, as the Polish oncology-focused ...

The US Food and Drug Administration (FDA) has accepted for priority review a new supplemental Biologics License Application ...